SORT BY

FILTER BY

also on other fortune lists

World's Most Admired Companies

Bristol-Myers Squibb

BMY

New York City

Looking for leads, investment insights, or competitive intelligence?

Industry

Pharmaceuticals

Location

New York City

Industry Ranking

6

Previous Industry Ranking

5

Previous Top 50 Ranking

-

Overall Score

6.84

Key Attributes of Reputation
Industry Rank
Innovation66%
People Management66%
Use of Corporate Assets66%
Social Responsibility55%
Quality of Management55%
Financial Soundness88%
Long-Term Investment Value77%
Quality of Products/Services44%
Global Competitiveness88%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Bristol-Myers Squibb

Celgene Boosted Price of Top Cancer Drug on Day of Mega-Deal

Celgene boosted the price of a 10-milligram dose of Revlimid by 3.5% to $719.82 effective Jan. 3.

Read More →
Russian Drugmaker Granted License to Produce Celgene Copycat

Russian drugmaker Nativa got a compulsory license to produce a cheaper version of Celgene's Revlimid.

Read More →
A Cancer Blockbuster Gets Approved in China. Will the Floodgates Now Open?

Chinese drug regulators gave the nod to Bristol-Myers Squibb’s immune therapy star Opdivo. Dozens of companies are hoping they’re next.

Read More →